Peter Fernandes - Dec 9, 2022 Form 4 Insider Report for Bellerophon Therapeutics, Inc. (BLPH)

Role: PRINCIPAL EXECUTIVE OFFICER
Signature: /s/ Peter Fernandes
Stock symbol: BLPH
Transactions as of: Dec 9, 2022
Transactions value $: -$9,287
Form type: 4
Date filed: 12/13/2022, 04:25 PM
Previous filing: Jan 28, 2022
Next filing: Feb 14, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLPH	Common Stock	Options Exercise		+32.5K			32.5K	Dec 9, 2022	Direct	F1
transaction	BLPH	Common Stock	Tax liability	-$9.29K	-9.99K	-30.72%	$0.93	22.5K	Dec 9, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BLPH	Restricted Stock Units	Options Exercise	$0	-32.5K	-50%	$0.00	32.5K	Dec 9, 2022	Common Stock	32.5K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock.
F2	On January 26, 2022, the reporting person was granted 65,000 restricted stock units, 50% vesting on December 9, 2022 and 50% vesting on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date.